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Abstract
X X  .2 ,5 -adenylate oligonucleotide 2-5A -dependent RNase and 2-5A-synthetase are two enzymes of the 2-5A system
strongly implicated in the basal control of RNA decay of both interferon-treated and untreated cells. RNase is activated by a
 .2-5A produced by 2-5A-synthetase, both enzymes being overexpressed by type I-interferon arb . We described here for
the first time a cell line completely deficient in RNase and its mRNA, while p69 2-5A-synthetase was normally interferon
 .arb-induced. The complete absence of this RNase in human hepatoma cells HepG2 was shown using three different
w32 xmethods based on the binding of a P -labeled 2-5A probe of high specific activity to its binding site. Negative Western
blotting assay with a specific monoclonal antibody correlated the previous findings. RNase-specific mRNA was not
detectable even after treatment of cells with 1000 unitsrml of interferon arb. This is not due to a mutation of the gene
because an intronless genomic DNA sequence encoding 2-5A-binding site was cloned and expressed. It is likely that the
expression of 2-5A-dependent RNase was impaired at the transcriptional level while having the known IFN arb-transcrip-
tional regulatory factors as revealed by induction of p69 2-5A-synthetase gene. This may account for a differential
activation of 2-5A-dependent RNase and 2-5A-synthetase genes by type I-interferon, and suggests that other members of
regulatory transcription factors, different from IRF-1 and STAT proteins, may participate in two different interferon arb
signaling pathways. q 1998 Elsevier Science B.V.
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1. Introduction
Regulation of mRNA degradation by post-tran-
scriptional mechanisms is a crucial event for cell
Abbreviations: IFN, interferon; IRF, interferon regulatory fac-
tor; JAK, Janus tyrosine kinase; STAT proteins, signal transduc-
tion and activator of transcription; ISGF, interferon-stimulated
gene factor; 2-5A, 2X,5X-oligoadenylate; ISRE, interferon stimula-
tory responsive element
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function, as it is one of the major means of regulating
w xgene expression 1,2 . The high stability of some
particular mRNA species contrasts with fast degrad-
 .ing species having some UA-rich UAR sequences
X w xlocated at the 3 untranslated region 3 . mRNA
decay due to the presence of destabilizing UAR
sequences has been demonstrated for some mRNAs,
w x w xsuch as c-fos, c-myc 4 and interferon b 5 . There is
limited information on the decay machinery, and
knowledge of potential UA-binding proteins having a
w xnuclease activity is still fragmentary 6,7 . In particu-
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lar, characterization of nucleases responsible for
mRNA decay process in mammalian cells is poorly
documented.
The interferon-regulated 2-5A system is at present
the only well-characterized RNA degradation path-
way in higher eucaryotes. mRNA degradation is me-
diated by the synergic action of two IFN arb-induci-
ble enzymes: the low abundant 2-5A-dependent
RNase that cleaves single-stranded regions of RNA
and the 2-5A-synthetase family that produces
X X nanomolar concentrations of 2 ,5 -oligoadenylates 2-
. w x5A for RNase activation 8 . A difference in gene
expression of these two enzymes was reported in IFN
arb-treated cells. A 2-5A-synthetase mRNA, not
expressed in a constitutive manner, was transiently
w xinduced 9 while 2-5A-dependent RNase gene was
transcribed at a basal level and enhanced 3- to 4-fold
w x10 . Cellular responses to interferon arb require its
binding with species-specific membrane receptors.
Soon after this interaction, the tyrosine kinases Tyk2
and JAK1 phosphorylate, three different latent
STAT-proteins, causing them to link up to each other
 .as a heterotrimeric complex ISGF3 , before their
nuclear translocation. In the nucleus, they bind the
smaller protein ISGF3grp48, forming the active tran-
scriptional complex that turns on the IFN-responsive
genes through specific binding with DNA element
 . w xISRE 11 . Moreover, in response to IFN, a distinct
signal transduction pathway leading to the synthesis
of an additional transcription factor, termed IRF-1,
was involved in the activation of IFN-genes and
some IFN-inducible genes upon binding to the same
w xISRE promoter sequence 12 . Activation of these
two pathways occurs in virus infected cells, but may
also participate in the uninfected cells to generally
w xcontrol RNA stability 13 . Direct evaluation of the
role of the 2-5A system in the antiviral and antiprolif-
erative effect of interferon arb-treated cells have
w xbeen widely documented 14,15 , and investigations
introducing 2-5A or stabilized 2-5A analogues into
cultured cells have led to a transient inhibition of
cellular and viral protein synthesis and concomitant
w xvirus inhibition 16–18 . More recently, cloning of
the murine and human 2-5A-dependent RNase pro-
vided an important tool for investigating the role
w xplayed by the 2-5A system 10,19–21 . The human
 .RNase gene RNS4 is encoding for a protein of 741
amino acids, and a repeated phosphate binding loop
 .P loop located at position 228–275 sequence is
w ximplicated in binding of target 2-5A 10 .
Previously, a cell line deficient in 2-5A-dependent
w xRNase has been described 22 and the missing en-
zyme further characterized using a more sensitive
w xmethod of detection 23 . This report describes for the
first time a human cell line lacking expression of
2-5A-dependent RNase and its mRNA while having
an interferon arb-inducible p69 2-5A synthetase
gene. These findings indicate that type I-interferon
signaling pathway was fully functional in HepG2
cells while unable to activate the human RNase gene.
Moreover, synthesis of IRF-1, induced by interferon
arb , was not impaired in those cells. This implies
 .that gene-specific transcription factor s , different
from IRF-1 and STAT proteins were specifically
implicated in the transcription of this gene.
2. Experimental
2.1. Preparation of cell extracts
 .Human lymphocyte leukemia cells Jurkat , human
lymphoblastoid Daudi cells and hepatoma cells
 . HepG2 from the American Type Culture Collec-
.tion were grown and maintained in RPMI 1640
medium, 10 mM glutamine supplemented with 10%
 .vrv fetal calf serum, 50 IUrml penicillin, and 50
mgrml streptomycin. Nuclei and cytoplasmic ex-
w xtracts were prepared as previously 24 . Cells were
washed twice with cold PBS and resuspended in
buffer A: 10 mM Tris–HCl, pH 7.6, 2 mM MgCl ,2
 .75 mM NaCl, 1 mM PMSF, 2% vrv Tween 40 and
disrupted by 30 strokes in a tight-fitting Dounce
homogenizer. The homogenate was centrifuged at
2000=g for 1 min and the cytosolic extract was
pipetted off to be stored in liquid nitrogen. The pellet
of nuclei was resuspended in 300 ml of buffer B 10
mM Tris–HCl, pH 7.6, 75 mM KCl, 1 mM EDTA, 7
mM 2-mercaptoethanol, 1.2 mM ATP, pH 7.6, 100
.mg leupeptin and 1 mM PMSF and layered on to
750 ml of 50% sucrose in buffer A. The pellet of
nuclei obtained after centrifugation was resuspended
in 300 ml of buffer B and stored in liquid nitrogen.
The morphology and apparent integrity of the nuclei
were assessed by electronic microscopy. Protein con-
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centration was determined with the Bradford assay
from Biorad.
2.2. Source of 2-5A probes
X X X 5 -phosphorylated 2 ,5 -linked oligoadenylates 2-
.5A were enzymically synthesized from ATP, with
partially purified 2-5A synthetases from interferon
w xarb-treated Hela S and HepG2 cells 25 . Interferon
 .type I arb was from Institut Merieux. Produced´
X  X X .ppp5A 2 p5A oligomers with 3-n-15 weren
w xfractionated on a DEAE-cellulose column 18 and
fractions containing individual oligomers were char-
acterized by reverse-phase HPLC on a mBondapak
w xcolumn by a described procedure 26 . The corre-
sponding 2-5A brom oadenylated analog
 X .  8 X .  .p A2 p Br A2 p A a gift from Dr. Torrence used2 2
in covalent binding reactions was prepared using a
w xsolid phase synthesis method 27 . The 2-5A labeled
w X 32 xprobes were obtained by ligation of 5 - P pCp
 6 . Xspecific radioactivity 3=10 Cirmol at the 3 end
w xwith T4 RNA ligase 28 and purified from the
w xnonreacting components by reverse-phase HLPC 26 .
2.3. Detection of 2-5A-dependent RNase with 2-5A
probes and monoclonal antibodies
A 2-5A-binding activity was measured by modifi-
w x w xcations 29 of the filter method 30 . A 2-5A-binding
activity was also estimated by the ultraviolet covalent
w xcross-linking procedure 31 . These two procedures
allowed the detection of 2-5A-dependent RNase free
of 2-5A. Total amounts of 2-5A-dependent RNase
was determined by denaturing–renaturing affinity
w xblotting assay 32 .
A 2-5A-dependent RNase was visualized by prob-
ing Western blots with monoclonal antibody against
 .RNase a gift from Dr. R. Silverman and B. Dong
followed with goat anti-mouse IgG-peroxidase Life
.Technologies and enhanced chemiluminescence
 .Amersham .
2.4. Immunodetection of IRF-1 and IRF-2 in nuclear
extracts
 .Cells were treated with IFN arb 500 IUrml for
4 h and nuclear extracts were prepared as previously
w xdescribed 33 . Western blot detection was performed
with polyclonal antibodies Santa Cruz Biotechnol-
.ogy followed with goat anti-rabbit IgG-peroxidase
 .Life Technologies and developed with reagents for
 .ECL Amersham .
2.5. Preparations of nucleic acids
Genomic DNA was extracted from cells using a
mixture of phenolrchloroformrisoamylic alcohol
 .25r24r1 and DNA was recovered by precipitation
with ethanol. Total cellular RNA was isolated using a
guanidinium thiocyanaterphenolrchloroform method
w x34 . RNA was reconstituted in RNase-free water and
stored at y708C. Concentration of nucleic acids was
determined by ultraviolet absorbance measurement
and quality of RNA was controlled by agarose gel
 .electrophoresis. Poly A -selected RNA was obtained
using the mRNA isolation kit of Boehringer
Mannheim and mRNA preparation was kept in alco-
hol at y208C. Primers for b-actin were from Strata-
gene and other primers were from Genosys.
2.6. RT-PCR
Reverse transcriptions were carried out with the kit
from Life Technologies according to the manufac-
turer’s instructions. A 10 mg of total cellular RNA,
 .used for b-actin and 2-5A-synthetase RT-PCR or
 . 5–10 mg of poly A -selected RNA used for b-actin,
.b 2 m-globuline and 2-5A-dependent RNase RT-PCR
were reverse transcribed with 5 pmol of either primer:
2819 bp-antisense 5X-TGC ATC CAG TGC CCA
GAC TTA-3X specific to 2-5A-dependent RNase;
primer 2548 bp-antisense 5X-GGA AGA AAA TTT
GCG GAT GA-3X specific to 2-5A-synthetase. The
 .reverse transcription mixture 5 ml containing the
first cDNA strand was used for amplification by
polymerase chain reaction with the following pairs of
oligonucleotides: primers specific to 2-5A-dependent
 . XRNase gene: y 28 bp-sense: 5 -AAA GTG GTA
GCA GGT GGC ATT TAC-3X and 1536 bp-anti-
sense: 5X-CCA GCC CAC TTG ATG CTC TTA
X  .TC-3 the expected fragment was 1564 bp ; 1061
bp-sense: 5X-CCG CCC TAT GAT TGG CAA ACT
C-3X and 1536 bp-antisense: 5X-CCA GCC CAC TTG
X ATG CTC TTA TC-3 the expected fragment was
. X475 bp ; 1495 bp-sense: 5 -GCT CAC CTG GCA
GAT TTT GAT AA-3X and 1831 bp- antisense: 5X-
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X CAG AAT TTT CGT GTT TTG ATG TCG G-3 the
. Xexpected fragment was 436 bp ; 1495 bp-sense: 5 -
GCT CAC CTG GCA GAT TTT GAT-3X and 2771
bp-antisense: 5X-AAT GAA TGA GAT TCC TGG
X  .AAC C-3 the expected fragment was 1276 ; primers
specific to p69 2-5A synthetase gene: 110 bp-sense:
5X-GGT GAA CAC CAT CTG TGA CG-3X and 2181
bp-antisense: 5X-TAA GCT CCT GTG AGC TGG
X  .GT-3 the expected fragment was 2071 bp ; primers
specific to IRF-1: -133 bp-sense 5X-CTT AAG AAC
CAG GCA ACC TCT G-3X and 1278 bp antisense
5X-TAC ACC ACA AGA AAA ACC CAG AC-3X;
primers specific to b 2 m-globuline: 155 bp-sense:
5X-CCA GCA GAG AAT GGA AAG TC-3X and 1040
bp antisense: 5X-TGA TGC TGC TTA CAT GTC T-3X
 .the expected fragment was 270 bp ; primers specific
to b-actin gene were from Stratagene. b-actin and
b 2 m-globuline were used as positive control. Am-
plified PCR products were excised and extracted
from an agarose gel as the major ethidium bromide
stained band using the gel extraction kit Jetsorb
 .Genomed .
2.7. DNA sequencing and sequence analysis
Amplified DNA segments were sequenced with
 .the Sequenase 2.0 DNA sequencing kit Amersham .
 .Nucleic acids were separated on a 6% wrv poly-
acrylamider8 M-urea gels. The resulting radiola-
beled bands were visualized by exposing the gel,
dried on Whatman 3 MM paper, to Kodak X-Omat
RP film for 15 h.
2.8. Preparation of clones for in ˝itro transcriptionr
translation
 XA set of primers 1 bp-sense 5 -ATG AAA GTG
X.GTA GCA GGT GGC ATT TAC-3 and 1224 bp-
 Xantisense 5 -TTG CAG ACA AGA GAC TTC CCG-
X.3 , flanked by NdeI and BamHI restriction sites,
were used in PCR to produce DNA segment 1-1224
from HepG2 and Jurkat genomic DNA. Following
confirmation of the correct sequence by deoxy chain
termination sequencing, fragments were digested by
NdeI and BamHI restriction enzymes before ligation
q.  .into the pET-23a vector from Novagen at the
NdeI and BamHI sites. The constructed plasmids
pET-HepG2 and pET-Jurkat, encoding the first 408
amino acids and including the 2-5A-binding site,
were introduced into Escherichia coli strain BL21
 .DE3 . Outgrowth colonies were grown to midlog
 .phase at 378C in Luria–Bertani medium LB con-
taining 50 mgrml of ampicillin. Cells were harvested
and plasmids isolated with the Wizard miniprep kit
 .Promega .
The in vitro coupled transcriptionrtranslation as-
say was performed with wheat germ extract as speci-
 .fied by the manufacturer Promega Biotech . Plas-
 .mids, pET-HepG2 and pET-Jurkat 1 mg each , were
linearized by digestion with restriction endonuclease
ScaI and transcribed with RNA polymerase T7. The
mRNAs produced in vitro were translated with 40
w35 xmCi of S methionine in 20 mM amino acids minus
methionine in a total volume of 20 ml. Transcrip-
tionrtranslation was carried out in the same tube at
308C for 1 h, radiolabeled proteins were separated by
 .SDS-PAGE 10% gels and visualized by exposing
the dried gel to Kodak X-Omat RP film. Unlabelled
 .methionine 20 m M was used instead of
w35 xS methionine and produced proteins were assayed
for 2-5A-binding activity with the ultraviolet covalent
cross-linking method. Proteins were separated in
SDS-PAGE and detected by auto-radiography of the
dried gel with Kodak X-Omat RP film.
3. Results
3.1. 2-5A-dependent RNase was not detectable in
HepG2 cells
This ubiquitous RNase is a very low abundant
protein found at nanomolar concentrations in cells
w xand tissues 35 therefore, very sensitive methods are
then required for its detection. In addition, 2-5A-de-
pendent RNase may exist in an inactive or latent
2-5A free form, or complexed with 2-5A in cyto-
w xplasm or nuclei 24 . Three assays were used for its
detection either in the cytoplasm or in nuclei. A
radio-binding assay allowed to detect 2-5A-binding
activity in cell extracts. An UV photo-cross-linking
procedure was particularly useful in 2-5A-free nucle-
w xase detection in polyacrylamide gel 31 , while total
nuclease was assessed with the denaturing–renaturing
w xaffinity blot assay 32 . Although a radioactive label-
ing of this nuclease was assayed with the radio-bind-
ing method, using a 2-5A probe of high specific
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 6 .activity 3=10 Cirmol , no traces of RNase was
detected in both the cytoplasm and nuclei of IFN
 .arb-treated HepG2 cells 16 h with 1000 IUrml
while in Daudi extracts the levels were estimated to
32 and 8 fmolrmg of protein, respectively. The UV
photo-cross-linking procedure did not allow to detect
traces of RNase in HepG2 and corroborate our obser-
vation, in contrast, Daudi and Jurkat cells, used as
control, exhibited a typical radiolabeled 78 kDa band
present at different levels in nuclei and cytoplasm
 .Fig. 1a . No traces of RNase in the cell extracts were
seen when HepG2 cells were triggered with IFN
 .arb , 1000 IUrml from 4 to 16 h, with intervals of
4 h, even using larger amounts of proteins 240, and
.350 mg in the assay.
As the nuclease detection assays were based on
2-5A-binding activity, the presence of this enzyme
with a nonfunctioning 2-5A site was not completely
excluded. Consequently, detection of this protein was
assessed in Western blotting assay with a monoclonal
antibody that recognized an epitope outside of the
2-5A site. The evidence shown in Fig. 1b corrob-
 .orates the data above Fig. 1a and strongly suggests
that 2-5A-dependent RNase was not detectable in
whole HepG2 cells. The absence of the RNase could
reflect either a fast degradation of the protein or a
deficient transcription process.
3.2. 2-5A-dependent RNase-specific mRNA was not
detectable in interferon arb-treated HepG2 cells
The limitations inherent to different available
methods of detection of rare mRNA led us to use the
reverse transcription procedure to generate first strand
 .cDNA followed by PCR-amplification RT-PCR .
Several studies concluded that this method is more
sensitive than both Northern blot and RNase protec-
 .tion assay RPA .
 .The same poly A -RNA preparation obtained from
IFN arb-treated Jurkat and HepG2 cells 1000
.IUrml for 15 h was used in all the RT-PCR experi-
ments. The quality of the affinity purified mRNA was
controlled by RT-PCR using a set of primers see
.Section 2 specific to b 2 m-globuline gene. The
amplified fragment obtained by RT-PCR from both
Jurkat and HepG2 mRNA preparation was 270 bp
 .and spanned an intron sequence 402–1017 that was
detected by direct PCR of the genomic DNA. Frag-
ment resulting from PCR of DNA with this set of
 .  .primers was 885 bp 155–1040 Fig. 2a .
 .  .  .Fig. 1. A 2-5A-dependent RNase was not detectable in HepG2 cells. Panel a —cytoplasmic extracts C and purified nuclei N from
 .HepG2, Jurkat and Daudi IFN arb-treated cells 1000 IUrml for 16 h were prepared as in Section 2 for 2-5A affinity with the 2-5A
binding site. 2-5A-dependent RNase was characterized by covalent cross-linking of the radiolabeled 2-5A probe. Each lane contained 140
mg of proteins estimated with the Bradford assay. The position of the proteins markers and their sizes in kDa are indicated. Panel
 .  .b —total extracts from Daudi, Jurkat and HepG2 interferon arb-treated cells 1000 IUrml for 16 h were prepared in the presence of
 .SDS electrophoretic sample buffer at 958C for 3 min. The mixture was sonicated and proteins 140 mg were separated by gel
electrophoresis followed by electrotransfer to nitrocellulose and incubation with specific monoclonal antibody. Bound antibodies were
revealed by chemiluminescence with a second goat mouse anti-IgG peroxidase antibody.
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Reverse transcription of mRNA encoding for 2-
5A-dependent RNase was performed using a single
 . Xprimer 2819 bp-antisense located at the 3 end of
the noncoding sequence. Four pairs of primer were
selected with Amplifier program to detect unique
sequence and to overlap the whole cDNA see Sec-
.tion 2 . Optimal conditions of high stringency were
used to yield a product spanning the intron–exons
junction, ensuring that the PCR product was mRNA
derived. To avoid artifacts due to the presence of
contaminated products, a negative control was per-
formed in each assay by omitting the reverse tran-
scriptase.
The four patterns of RT-PCR obtained by compari-
son with Jurkat and HepG2 mRNA were shown in
Fig. 2b and c. No traces of amplified cDNA was
detected in HepG2 cells treated with different con-
 .centrations of interferon type I 500 and 1000 IUrml
and for different induction times from 4 to 16 h not
.shown . Amplified products only obtained with Ju-
rkat cDNA using four pairs of primers were partially
sequenced and correspond to the nuclease sequence
w x10 . In Jurkat cells, 2-5A-dependent RNase mRNA
level was enhanced 5-fold by IFN arb 500 and
.1000 IUrml, 4 h . No difference was observed be-
tween these two IFN-concentrations, but interest-
ingly, the signal returned to the basal level in the
 .presence of cycloheximide Fig. 3 . In the absence of
IFN-treatment the constitutive basal mRNA level was
not affected by cycloheximide. Invariant levels of
b-actin amplified product indicated that equivalent
amount of RNA was present in each lane and that
 .RT-PCR was reproducible not shown . These results
show that induction of 2-5A-dependent RNase is not
a primary response to interferon-treatment. The ab-
Fig. 2. A 2-5A-dependent RNase specific mRNA was not de-
tectable in HepG2 cells. First strand cDNA was obtained by
 .reverse transcription of poly A -selected RNA purified from IFN
 .  . ar b-treated HepG2 H and Jurkat J cells 1000 IUrml for 15
.  .h . Panel a —the quality of the mRNA was assayed using a set
of primers spanning an intron–exon junction of the gene and was
specific to b 2 m-globuline. The amplified RT-PCR product of
270 bp was compared with a PCR fragment of 900 bp obtained
 .  .from the genomic DNA. Panel b , c —amplification of cDNA
was performed with four pair of primers overlapping the whole
 .2-5A dependent RNase cDNA see Section 2 . Control was
obtained by omitting the reverse transcriptase in the assay lanes
.y .
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Fig. 3. Interferon induction of 2-5A dependent RNase mRNA in
the presence or absence of cycloheximide. First-strand cDNA
was synthesized as in Fig. 2 from Jurkat cells treated with
 .interferon ar b 1000 IUrml for 4 h andror cycloheximide
 .CHX at 50 mgrml. The primers y28-sense and 1536-antisense
specific to 2-5A dependent RNase were used in RT-PCR, the
amplified product corresponding to a fragment of 1.6 kb was
electrophoretically resolved in 1.2% agarose gels and revealed
with ethidium bromide reagent.
sence of 2-5A-dependent RNase mRNA in HepG2
cells could reflect either a misfunctioning transcrip-
tional process or an unstable mRNA.
3.3. 2-5A binding site from HepG2 genome is func-
tional
Naturally occurring and cloned human 2-5A-de-
pendent RNase produced in vitro exhibits identical
2-5A-binding properties and ribonuclease specifici-
w xties 10 . Sequences involved in 2-5A-binding site
were reported by the same authors to span the region
680–822 of the cDNA. To obtain recombinant pro-
tein for characterization of 2-5A-binding site, the 5X
terminal half part of the genomic DNA was cloned,
transcribed and translated in cell-free system. A ge-
nomic fragment spanning bases 1 to 1224 was ob-
tained by PCR amplification of HepG2 and Jurkat
purified DNA. After sequencing, this fragment was
found intronless and identical to the published se-
quence of the human 2-5A-dependent RNase cDNA
w x  .10 . The intronless fragment 1–1224 bp , containing
the potential 2-5A-binding site, was cloned into the
q.  .plasmid pET-23a Novagen at NdeI and BamHI
sites, downstream of the T7 promoter. ScaI linearized
plasmids were simultaneously transcribed and trans-
lated in wheat germ extract with or without
w35 xS methionine. For both Jurkat and HepG2 cells, a
w35 xS synthesized polypeptide of 43 kDa apparent
molecular mass was detected in SDS-PAGE Fig.
.4a . Unlabelled 43 kDa polypeptide was produced to
explore the presence of a functional 2-5A-binding
w xsite using the covalent cross-linking method 31 .
Assay was performed with or without an excess of
 .unlabelled 2-5A as competitor Fig. 4b . Significant
specific cross-linking of 2-5A probe to the produced
43 kDa peptide was obtained with both plasmid
constructs. These results clearly demonstrate that the
recombinant HepG2 43 kDa polypeptide produced in
vitro has functional 2-5A-binding site. The lack of
RNase expression in HepG2 cells was impaired at the
transcriptional level.
3.4. p69 2-5A-synthetase was induced by interferon
arb in HepG2 cells
Type I interferon regulates the 2-5A pathway by
w xelevating levels of both 2-5A-synthetase 36 and
w x2-5A-dependent RNase 10 , both enzymes might be
impaired in HepG2 cells. To probe this question,
induction by interferon arb of 2-5A-synthetase was
investigated at the mRNA level. Four isoforms of
2-5A-synthetase family have been identified 40, 44,
. w x69 and 100 kDa 14,36,37 . Our study was limited to
the p69 isoform as the cDNA was previously well
w xcharacterized 38 .
In our experiments, cells were pretreated with or
without cycloheximide for 4 h with IFN arb 250
.IUrml , and the level of mRNA was estimated by
RT-PCR using a set of primers specific to p69 2-5A-
 .synthetase see Section 2 . A clear induction of p69
mRNA was observed in HepG2 cells treated with
IFN arb. Remarkably, the mRNA level was strictly
identical for both HepG2 and Jurkat cells used as
control. As shown in Fig. 5a, two amplified-bands, a
minor 1.0 kb and a more abundant 2.1 kb band, were
obtained only in IFN arb-treated cells. The 1.0 kb
band was considered as a nonspecific product and
was not sequenced. The 2.1-kb product, having the
expected size, was partially sequenced and was re-
lated to the p69 protein. In unstimulated cells, no
detectable mRNA level was found in HepG2 and
Jurkat cells. In contrast to RNase, the appearance of
transcripts was not affected by cycloheximide
demonstrating that ongoing protein synthesis is not
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 . w35 xFig. 4. Simultaneous in vitro transcriptionrtranslation. Panel a — S -labeled proteins were obtained with the transcriptionrtranslation
 .  .  .system Promega using the constructed plasmids pET-Jurkat lane J and pET-HepG2 lane H linearized by ScaI. A negative control
 .  .was performed by omitting the template lane C . Panel b —unlabelled proteins obtained in the same conditions were assayed for
 .2-5A-binding activity with the photochemical cross-linking procedure see Section 2 and bands of 43 kDa were revealed by cross-linking
 X .  8 X . X w32 x  .of labeled 2-5A. Assays were realized using 30 000 countsrmin of p A2 p br A2 p A3 - P Cp probe in the presence lane q or2 2
 .  X.absence lane y of 500 nM p A2 A used as competitor. On the left side, native 80 kDa RNase from Jurkat cell extract was used as3 3
positive control for 2-5A binding assay.
 .Fig. 5. Induction of 2-5A-synthetase mRNA in interferon arb-treated HepG2 and Jurkat cells. Panel a —first-strand cDNA was
 .  .obtained by reverse transcription of total RNA purified from HepG2 H and Jurkat J cells untreated or treated for 4 h with interferon
 .  .arb 250 IUrml using the primer 2548 bp-antisense. A control was performed in each assay by omitting the RT see Section 2 .
Amplification of cDNA was assessed by PCR with a set of primers 110-sense and 2181-antisense specific to p69 2-5A synthetase.
 .Amplified products were analyzed in 1.2% 1=TBE agarose gels and revealed with ethidium bromide. Panel b —HepG2 and Jurkat
 .  .  .cells were treated with interferon arb 250 IUrml for 4 h andror cycloheximide 50 mgrml CHX . Amplified products were
 .analyzed as described in panel a .
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required and that 2-5A-synthetase gene expression is
regulated as a primary response to interferon treat-
 .ment Fig. 5b . Furthermore, 2-5A-synthetase activity
was monitored in these two interferon-treated cell
w xlines by incorporation of ATP into 2-5A 25 . A
characteristic pattern of synthesized 2-5A oligomers
was obtained by reverse-phase HPLC data not
.shown . These findings demonstrate that IFN arb
triggered the signaling pathway leading to the induc-
tion of p69 2-5A synthetase in HepG2 cells. Binding
of ISGF3 to the entire ISRE induces transcriptional
induction of this gene upon treatment of cells with
type I interferon.
3.5. Interferon regulatory factors IRF-1, IRF-2 are
expressed in IFN arb-treated HepG2 cells
It is known from earlier studies that accumulation
of IRF-1 appears to be essential for its binding to
ISRE sequences and induction of the corresponding
w xgene 39,40 . A previous report showed that HepG2
cells expressed a faint band of truncated IRF-1 while
w xIRF-2 was normally expressed 41 . Therefore, we
addressed the question whether the balance of IRF-1
transcriptional activator and IRF-2 transcriptional re-
pressor was affected in HepG2 cells. By using the
anti-IRF-1 and IRF-2 antiserums, we next determined
the presence of IRF-1 and IRF-2 protein and their
relative molecular masses by Western blotting. As
shown in Fig. 6a, IRF-1- and IRF-2-encoded pro-
teins, not truncated, migrated with apparent molecu-
lar masses of 56 kDa and 36 kDa, respectively in
both cell lines. p56rIRF-1 was present at the same
levels in nuclear extracts prepared from interferon
 .arb 500 IUrml for 4 h -treated HepG2 and Jurkat
cells. This finding was confirmed by amplification of
the IRF-1 mRNA using a set of specific primers see
.Section 2 . An amplified product of 1300 bp corre-
 .Fig. 6. Molecular masses and levels of IRF-1 and IRF-2 in interferon arb-treated Jurkat and HepG2 cells. Panel a —Western blot
 .  .  .analysis of IRF-1 and IRF-2 prepared from nuclei of Jurkat J and HepG2 H cells treated with interferon arb 500 IUrml for 4 h.
The sizes of IRF-1 and IRF-2, revealed with specific antibodies and chemiluminescence, are indicated on the left. For detection of IRF-2,
 .120 mg of total proteins were loaded in SDSracrylamide gels against 25 mg for IRF-1. Panel b —immunodetection and comparison of
 .levels of IRF-1 and IRF-2 in nuclei of HepG2 cells treated by interferon arb 500 IUrml for different periods of time 0, 2, 4 and 6 h.
 .  .Proteins 25 mg in each lane from purified nuclei were analyzed in Western blots as in panel a .
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sponding to the whole IRF-1 cDNA was obtained
 .not shown attesting that IRF-1 was not truncated.
We also examined the inductions of IRF-1 and IRF-2
proteins by treatment of HepG2 cells for 2, 4 and 6 h
 .with type I-interferon 500 IUrml . Western blot
analysis revealed that p36rIRF-2 was not induced by
IFN. In IFN-unstimulated cells, IRF-1 was detected
at a basal level and accumulation increased within 2
h after IFN arb addition and protein levels reached
 .a plateau between 4–6 h Fig. 6b . These results
implied that expression of enzymes of the 2-5A
system, both known to be triggered by IFN arb
were induced by two different signalling pathways
each being specific to 2-5A-synthetase and 2-5A-de-
pendent RNase. In summary, these results suggest
that both IRF-1 and ISGF3 are not sufficient for
transcriptional activation of the chromosomal 2-5A-
dependent gene in HepG2 cells.
4. Discussion
A previous report has described a cell line defi-
w xcient in 2-5A-dependent RNase 22 , but the subse-
quent development and use of very sensitive methods
have shown that the missing enzyme can be further
w xdetected 23 . For this reason, special cares were
taken in this study to provide strong evidence that
2-5A-dependent RNase was completely absent in
HepG2 cells. Consequently, 2-5A-binding activity
 6was assayed with a high specific activity 3=10
.Cirmol 2-5A probe, which allowed the detection of
less than 0.05 fmol of enzyme. In addition, to ex-
clude a transient localization in a different compart-
ment of the cells that could render the enzyme unde-
w xtectable 42 , characterization of the 2-5A-binding
site was performed both in detergent-treated cyto-
plasm and nuclei. As demonstrated by in vitro tran-
scriptionrtranslation, the HepG2 RNase gene con-
tained the proper sequences for a functional 2-5A-bi-
 .nding site Fig. 4 while the transcript was not de-
tected by RT-PCR when using sets of primers span-
ning the whole cDNA.
Interferon arb-inducible genes contained a pro-
 .moter region ISRE-like sequence s which are usu-
w xally required for expression 43 but these cis-acting
elements are not yet known for the RNase gene. It
seems unlikely however, that an alteration of this
regulatory region was implicated in the lack of ex-
pression of this gene, since recently, Konan and
w xTaylor 41 reported a total lack of the IFN-induced
 .indoleamine 2,3-dioxygenase INDO in HepG2 cells.
Like for RNase, INDO-specific mRNA and was not
detected even after IFN-treatment. Furthermore, as
2-5A-synthetase was strongly induced in those cells
 .following IFN-treatment Fig. 5 , we can assume that
HepG2 cell line contains a functional signaling path-
way leading to p69 2-5A synthetase gene induction.
Lack of INDO and RNase expression could be im-
paired at the same level of a deficient signaling
pathway. A previous report has shown that IRF-1 was
strongly implicated in the induction of INDO gene
w x44 , and recent studies indicated that IRF-1 was
unstable and truncated in HepG2 cells in correlation
w xwith the lack of INDO expression 41 . Here, we
showed that IRF-1 mRNA was normally IFN-in-
duced, stable and not truncated in those cells. In
addition, we observed using specific polyclonal anti-
bodies that p56rIRF-1 protein was synthesized and
overexpressed following IFN-treatment. The reason
for this discrepancy remained unknown and could be
due to different extraction procedures. Two struc-
turally related transcriptional factors IRF-1 and IRF-2
have been identified that bind to the same DNA
sequence ISRE found in many IFN-inducible gene
w xpromoters 33 . IRF-1 and IRF-2 act in a mutually
antagonistic manner by competing for binding to the
w xsame ISRE 43 . In this work, IRF-2 was also identi-
cally expressed in both IFN-treated HepG2 and Ju-
rkat cells, but as expected at a lower level than IRF-1
with respect that polyclonal antibodies exhibit the
same affinity.
Both 2-5A-synthetase and 2-5A-dependent RNase
gene expressions are induced and overexpressed, re-
spectively upon IFN arb stimulation. Remarkably,
cycloheximide treatment completely abolished over-
 . expression of RNase Fig. 3 and INDO gene data
.not shown while 2-5A-synthetase remained unaf-
 .fected Fig. 5 . These results suggest requirement of
protein synthesis for RNase and INDO gene induc-
tion upon IFN arb-treatment. At the difference to
2-5A-synthetase, 2-5A-dependent RNase showed a
basal transcriptional level in Jurkat cells which was
not affected by cycloheximide. Taken together, these
observations suggested that an uncharacterized IRF-1
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coactivator is missing or that an unknown repressor is
present in HepG2 cells.
The nature of the intracellular signals that is impli-
cated in the specific transcriptional activation of 2-
5A-dependent RNase and INDO gene remains quite
obscure. It has been shown that some viruses can
bypass the interferon antiviral effect. E1A adenovirus
protein can suppress transcriptional induction of
IFN-stimulated genes without interacting with DNA
sequences but inhibiting ISGF3 or IRF-1 association
w xwith ISRE sequences 45,46 . Other DNA viruses,
such as Herpes and Hepatitis, also employ similar
w xstrategy to escape IFN antiviral effect 47,48 . It is
possible that HepG2 interferon response deficiency is
due to a viral protein which could interact with a
transcriptional factor. HepG2 cell line represents a
particular valuable tool for further studies on tran-
scriptional regulations of IFN-inducible genes.
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